LNTH

LANTHEUS HLDGS INC

LNTH·516544103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

LNTH (LANTHEUS HLDGS INC) is held by 194 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($931.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($619.4M), FMR LLC ($430.4M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 102 funds bought LNTH.

194
Holders
(16 Elite)
$6.6B
Total Value
53% (192)
Consensus
102 buying - 90 selling
13F: Insider & Congress: Updated regularly
LNTH

Smart Money Verdict

View all
Loading verdict
Held by 194 funds
16 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Aug 19, 2026 · Activists Jul 31, 2026 · Congress Feb 11, 2025

InsiderBKBrown KimberlyTax 463 shAug 17, 2026
InsiderDLDinkelborg LudgerTax 3K shAug 17, 2026
ActivistVPVanguard Portfolio Management5.1%Jul 31, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.4M(+2.6%)$931.6M0.0%+12.22%
33
Unchanged
5.6M$619.4M2.9%+28.71%
0
Decreased
3.9M(-16.1%)$430.4M0.0%+18.90%
0
Increased
3.2M(+2.0%)$359.3M0.0%+26.79%
32
Increased
2.9M(+0.6%)$325.3M0.0%+27.50%
31
Increased
2.8M(+58.1%)$312.5M0.1%+14.19%
53
Increased
2.5M(+2.9%)$277.4M0.0%+54.80%
32
Increased
1.8M(+4.3%)$204.3M0.0%+146.74%
32
Increased
1.7M(+4.8%)$191.5M0.0%+69.23%
32
Increased
1.5M(+6.3%)$162.7M0.0%+21.34%
32
Increased
1.4M(+383.8%)$152.7M0.0%-1.12%
49
Decreased
1.2M(-2.2%)$133.3M0.1%+23.93%
0
Increased
1M(+31.8%)$112.4M0.0%+14.94%
38
Increased
915,683(+33.2%)$101.6M0.2%+16.05%
46
Decreased
835,494(-3.7%)$92.7M0.0%+26.27%
0
Increased
818,394(+1.7%)$90.8M0.0%+187.49%
30
Increased
814,096(+46.5%)$90.3M0.0%+9.61%
41
Increased
773,978(+26.5%)$85.9M0.1%+21.00%
37
Increased
714,980(+440.4%)$79.3M0.1%-1.36%
48
Increased
699,583(+21.1%)$77.6M0.3%+28.94%
42

Showing 1-20 of 210

1 / 11
LNTHLNTHLANTHEUS HLDGS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used